News
Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the ...
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit ...
Many companies face FDA complete response letters due to ongoing chemistry, manufacturing, and controls, or CMC, and ...
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, ...
A federal judge dismissed a lawsuit accusing Intel of defrauding shareholders by concealing problems in a business where it ...
Fintel on MSN3d
BMO Capital Downgrades Replimune Group (REPL)Fintel reports that on July 23, 2025, BMO Capital downgraded their outlook for Replimune Group (NasdaqGS:REPL) from Outperform to Underperform. Analyst Price Forecast Suggests 595.73% Upside As of ...
Fintel on MSN4d
Wedbush Downgrades Replimune Group (REPL)Fintel reports that on July 22, 2025, Wedbush downgraded their outlook for Replimune Group (NasdaqGS:REPL) from Outperform to Neutral. Analyst Price Forecast Suggests 725.97% Upside As of July 17, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback